Skip to main content
Erschienen in: American Journal of Clinical Dermatology 3/2001

01.06.2001 | Therapy in Practice

Optimal Management of Acne to Prevent Scarring and Psychological Sequelae

verfasst von: Dr Alison M. Layton

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 3/2001

Einloggen, um Zugang zu erhalten

Abstract

Acne vulgaris is one of the most common inflammatory dermatoses and is seen in both the hospital setting and in general practice. Multiple factors are involved in the pathophysiology of acne, including: an alteration in the pattern of keratinization within the pilosebaceous follicles resulting in comedone formation; an increase in sebum production which is influenced by androgens; the proliferation of Propionibacterium acnes; and the production of perifollicular inflammation. Genetic and hormonal factors may also contribute to acne. Better understanding of the pathophysiology of the disease has led to the development of novel therapies which are directed at one or more of the implicated etiologic factors.
Systemic antibiotics for acne have been the mainstay of treatment for many years. The main cause for concern following the use of systemic antibiotics is the emergence of antibiotic-resistant strains of P. acnes. Concomitant use of non-antibiotic therapies such as benzoyl peroxide helps to decrease the occurrence of resistance and can be effective in the treatment of resistant and nonresistant propionibacterial strains. However, no one agent is able to eradicate resistant strains completely and as resistant strains correlate to poor clinical response to therapy, prescribing strategies are required to minimize the occurrence of resistance to P. acnes.
When assessing acne it is important to take an all embracing approach and to examine carefully for both the clinical and psychologic effects of the disease process. There are numerous forms of acne scarring and it is important to be aware of these as patients who are developing scarring merit early effective therapy. Some patients with acne will develop psychologic problems as a consequence of their condition. Even mild to moderate disease can be associated with significant depression and suicidal ideation and psychologic change does not necessarily correlate with disease severity. Acne scars themselves have been shown to produce significant psychopathology.
When initiating treatment it is important to consider the aims of therapy. Treatment should be aimed at achieving clearance of acne, prevention of scarring and, where necessary, relief from any psychologic stress resulting from the acne. Therapy should be commenced early in the disease process in order to prevent scarring and it is important to select appropriate therapies according to the clinical signs and psychologic disability. It is also important to ensure that the patient is able to comply with therapy and clear guidelines regarding treatment, possible adverse effects and realistic expectations should be provided.
Literatur
1.
Zurück zum Zitat Eady E.A., Cove J.H., Cunliffe W.J. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol 1989; 121: 51–57PubMedCrossRef Eady E.A., Cove J.H., Cunliffe W.J. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol 1989; 121: 51–57PubMedCrossRef
2.
Zurück zum Zitat Lleyden J.J. Therapy for acne vulgaris — review article. N Engl J Med 1997; 336: 1156–1162CrossRef Lleyden J.J. Therapy for acne vulgaris — review article. N Engl J Med 1997; 336: 1156–1162CrossRef
3.
Zurück zum Zitat Leyden J.J., McGinley K.H., Cavalierie S., et al. Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol 1983; 8: 41–45PubMedCrossRef Leyden J.J., McGinley K.H., Cavalierie S., et al. Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol 1983; 8: 41–45PubMedCrossRef
4.
Zurück zum Zitat Farmery M.R., Jones C.E., Eady E.A., et al. In vitro activity of azeleic acid, benzoyl peroxide and zinc acetate against anti biotic-resistant propionibacteria from acne patients. J Dermatol Treat 1994; 5: 63–65CrossRef Farmery M.R., Jones C.E., Eady E.A., et al. In vitro activity of azeleic acid, benzoyl peroxide and zinc acetate against anti biotic-resistant propionibacteria from acne patients. J Dermatol Treat 1994; 5: 63–65CrossRef
5.
Zurück zum Zitat Bojar R.A., Eady E.A., Jones C.E., et al. Inhibition of erythromycin resistant propionibacteria on the skin of acne patients by combining topical erythromycin with and without zinc. Br J Dermatol 1994; 130: 329–336PubMedCrossRef Bojar R.A., Eady E.A., Jones C.E., et al. Inhibition of erythromycin resistant propionibacteria on the skin of acne patients by combining topical erythromycin with and without zinc. Br J Dermatol 1994; 130: 329–336PubMedCrossRef
6.
Zurück zum Zitat Eady E.A., Bojar R.A., Jones C.E., et al. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin resistant propionibacteria. Br J Dermatol 1996; 134: 107–113PubMedCrossRef Eady E.A., Bojar R.A., Jones C.E., et al. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin resistant propionibacteria. Br J Dermatol 1996; 134: 107–113PubMedCrossRef
7.
Zurück zum Zitat Coates P., Adams C.A., Cunliffe W. Does oral isotretinoin prevent propionibacterium acnes resistance? Dermatology 1997; 195 Suppl. 4–9PubMedCrossRef Coates P., Adams C.A., Cunliffe W. Does oral isotretinoin prevent propionibacterium acnes resistance? Dermatology 1997; 195 Suppl. 4–9PubMedCrossRef
8.
Zurück zum Zitat Eady E.A., Jones C.E., Tipper, LE, et al. Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage. BMJ 1997; 306 (6877): 555–556CrossRef Eady E.A., Jones C.E., Tipper, LE, et al. Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage. BMJ 1997; 306 (6877): 555–556CrossRef
9.
Zurück zum Zitat Kirkup M.E., Dunill M.C.S. Management of acne prior to referral for isotretinoin therapy. Br J Dermatol 1999; 141 Suppl. 55: 53 Kirkup M.E., Dunill M.C.S. Management of acne prior to referral for isotretinoin therapy. Br J Dermatol 1999; 141 Suppl. 55: 53
10.
Zurück zum Zitat Layton A.M., Seukeran D., Cunliffe W. Scarred for life? Dermatology 1997; 195 Suppl.: 15–21PubMedCrossRef Layton A.M., Seukeran D., Cunliffe W. Scarred for life? Dermatology 1997; 195 Suppl.: 15–21PubMedCrossRef
11.
Zurück zum Zitat Sulzberger M.B., Zaidens S.H. Psychogenic factors in dermatologic disorders. Med Clin North Am 1948; 32: 669PubMed Sulzberger M.B., Zaidens S.H. Psychogenic factors in dermatologic disorders. Med Clin North Am 1948; 32: 669PubMed
12.
Zurück zum Zitat Kenyon F.E. Psychosomatic aspects of acne. Br J Dermatol 1966; 78: 344–351CrossRef Kenyon F.E. Psychosomatic aspects of acne. Br J Dermatol 1966; 78: 344–351CrossRef
13.
Zurück zum Zitat Rubinov D.R. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 1987; 17 (1): 25–32CrossRef Rubinov D.R. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 1987; 17 (1): 25–32CrossRef
14.
Zurück zum Zitat Shuster S., Fisher G.H., Harris E., et al. The effect of skin disease on self image. Br J Dermatol 1978; 99 Suppl. 16: 18–19PubMedCrossRef Shuster S., Fisher G.H., Harris E., et al. The effect of skin disease on self image. Br J Dermatol 1978; 99 Suppl. 16: 18–19PubMedCrossRef
15.
Zurück zum Zitat van der Meeram H.L., van der Schoor W.W., van der Hib C.M. The psychological impact of severe acne. Cutis 1985; 36: 84–86 van der Meeram H.L., van der Schoor W.W., van der Hib C.M. The psychological impact of severe acne. Cutis 1985; 36: 84–86
16.
Zurück zum Zitat Gupta M.A., Gupta A.K. Depression and suicidal ideation in dermatology patients with acne, alopecia, areata, atopic dermatitis and psoriasis. Br J Dermatol 1998; 139: 846–850PubMedCrossRef Gupta M.A., Gupta A.K. Depression and suicidal ideation in dermatology patients with acne, alopecia, areata, atopic dermatitis and psoriasis. Br J Dermatol 1998; 139: 846–850PubMedCrossRef
17.
Zurück zum Zitat Seukeran D.C., Cunliffe W.J., Islam J., et al. The psychological impact of acne scarring. Br J Dermatol 1999; 144 Suppl. 55: 54 Seukeran D.C., Cunliffe W.J., Islam J., et al. The psychological impact of acne scarring. Br J Dermatol 1999; 144 Suppl. 55: 54
18.
Zurück zum Zitat Brosden R.N., Goa R.L. Adapalene. A review of its pharmacological properties and clinical potential in the management of mild to moderate acne. Drugs 1997; 53 (5): 511–519CrossRef Brosden R.N., Goa R.L. Adapalene. A review of its pharmacological properties and clinical potential in the management of mild to moderate acne. Drugs 1997; 53 (5): 511–519CrossRef
19.
Zurück zum Zitat Cunliffe W.J., Holland K.T. The effect of benzoyl peroxide on acne. Acta Dermatol Venereol 1981; 61: 267–269 Cunliffe W.J., Holland K.T. The effect of benzoyl peroxide on acne. Acta Dermatol Venereol 1981; 61: 267–269
20.
Zurück zum Zitat Eady E.A., Cove J.H., Jones D.N., et al. Topical antibiotics for the treatment of acne vulgaris: a critical evaluation of the literature on their clinical benefit and comparative efficacy. J Dermatol Treat 1990; 1: 215–218CrossRef Eady E.A., Cove J.H., Jones D.N., et al. Topical antibiotics for the treatment of acne vulgaris: a critical evaluation of the literature on their clinical benefit and comparative efficacy. J Dermatol Treat 1990; 1: 215–218CrossRef
21.
Zurück zum Zitat Chu T. The role of topical retinoids in the treatment of acne. CME Dermatol Bull 2000; 2: 53–55 Chu T. The role of topical retinoids in the treatment of acne. CME Dermatol Bull 2000; 2: 53–55
22.
Zurück zum Zitat Eady E.A., Jones C.E., Tipper C.L. Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage. BMJ 1993; 306: 555–556PubMedCrossRef Eady E.A., Jones C.E., Tipper C.L. Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage. BMJ 1993; 306: 555–556PubMedCrossRef
23.
Zurück zum Zitat Cunliffe W.J.. Propionibacteria acnes resistance and its clinical relevance. J Dermatol Treat 1995; 6 (Suppl. 1): 53–54 Cunliffe W.J.. Propionibacteria acnes resistance and its clinical relevance. J Dermatol Treat 1995; 6 (Suppl. 1): 53–54
24.
Zurück zum Zitat Greenwood K., Brommitt I.L., Burke B. Acne: double blind clinical and laboratory trial of tetracycline, oestrogen cyproterone acetate and combined treatment. BMJ 1985; 291: 1231–1235PubMedCrossRef Greenwood K., Brommitt I.L., Burke B. Acne: double blind clinical and laboratory trial of tetracycline, oestrogen cyproterone acetate and combined treatment. BMJ 1985; 291: 1231–1235PubMedCrossRef
25.
Zurück zum Zitat Hammerstein J., Meckier J., Leo-Rossburg I., et al. Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism. J Steroid Biochem 1975; 6: 827–836PubMedCrossRef Hammerstein J., Meckier J., Leo-Rossburg I., et al. Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism. J Steroid Biochem 1975; 6: 827–836PubMedCrossRef
26.
27.
Zurück zum Zitat Layton A.M., Hughes B.R., MacDonald-Hull S., et al. Seborrhoea — an indicator for clinical response in acne patients treated with antibiotics. Clin Exp Dermatol 1992; 17: 173–175PubMedCrossRef Layton A.M., Hughes B.R., MacDonald-Hull S., et al. Seborrhoea — an indicator for clinical response in acne patients treated with antibiotics. Clin Exp Dermatol 1992; 17: 173–175PubMedCrossRef
28.
Zurück zum Zitat Layton A.M., Knaggs H., Taylor J., et al. Isotretinoin for acne vulgaris — 10 years later: a safe and successful treatment. Br J Dermatol 1993; 129: 292–296PubMedCrossRef Layton A.M., Knaggs H., Taylor J., et al. Isotretinoin for acne vulgaris — 10 years later: a safe and successful treatment. Br J Dermatol 1993; 129: 292–296PubMedCrossRef
29.
Zurück zum Zitat Millard L. Adverse mood and behaviour change in young patients on systemic isotretinoin. Br J Dermatol 1999; 141 Suppl. 55: 16 Millard L. Adverse mood and behaviour change in young patients on systemic isotretinoin. Br J Dermatol 1999; 141 Suppl. 55: 16
30.
Zurück zum Zitat Lee M.L., Cooper A. Isotretinoin: cost benefit study. Aust J Dermatol 1991; 32: 17–20CrossRef Lee M.L., Cooper A. Isotretinoin: cost benefit study. Aust J Dermatol 1991; 32: 17–20CrossRef
31.
Zurück zum Zitat Cunliffe W.J., van der Kerkhof P.C.M., Capcto R., et al. Roaccutane treatment guidelines: results of an international survey. Dermatology 1997; 194: 351–357PubMedCrossRef Cunliffe W.J., van der Kerkhof P.C.M., Capcto R., et al. Roaccutane treatment guidelines: results of an international survey. Dermatology 1997; 194: 351–357PubMedCrossRef
32.
Zurück zum Zitat Newton J.N., Mullan E., Klassen A., et al. The effectiveness of acne treatment: an assessment by patients of the outcome of therapy. Br J Dermatol 1997; 137 (4): 563–567PubMedCrossRef Newton J.N., Mullan E., Klassen A., et al. The effectiveness of acne treatment: an assessment by patients of the outcome of therapy. Br J Dermatol 1997; 137 (4): 563–567PubMedCrossRef
33.
Zurück zum Zitat Kellet S., Gawkrodger D.J.. The psychological and emotional impact of chronic acne and the effect of treatment with isotretinoin. Br J Dermatol 1998; 139 Suppl. 51: 56 Kellet S., Gawkrodger D.J.. The psychological and emotional impact of chronic acne and the effect of treatment with isotretinoin. Br J Dermatol 1998; 139 Suppl. 51: 56
Metadaten
Titel
Optimal Management of Acne to Prevent Scarring and Psychological Sequelae
verfasst von
Dr Alison M. Layton
Publikationsdatum
01.06.2001
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 3/2001
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200102030-00002

Weitere Artikel der Ausgabe 3/2001

American Journal of Clinical Dermatology 3/2001 Zur Ausgabe

Review Article

Vitiligo

Review Article

Estrogen and Skin

Adis New Drug Profile

Topical Eflornithine

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

16.04.2024 DGIM 2024 Nachrichten

Den Reflex, eine oberflächliche chronische Hautwunde ohne Entzündungszeichen in jedem Fall abzustreichen, sollte man nach einer neuen „Klug-entscheiden“-Empfehlung unterdrücken.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.